Journal of the American College of Cardiology
短名 | J. Am. Coll. Cardiol. |
Journal Impact | 21.78 |
国际分区 | CARDIAC & CARDIOVASCULAR SYSTEMS(Q1) |
期刊索引 | SCI Q1中科院 1 区 |
ISSN | 0735-1097, 1558-3597 |
h-index | 493 |
国内分区 | 医学(1区)医学心脏和心血管系统(1区) |
Top期刊 | 是 |
作为该领域的领导者,JACC 发表了关于心血管疾病各个方面的原始同行评审临床和实验报告。涵盖的主题包括冠状动脉和瓣膜疾病、先天性心脏缺陷、血管手术、心肌病、药物治疗、新诊断技术、实验室研究结果以及新疗法的大型多中心研究。 JACC 还出版在美国心脏病学会年度科学会议上发表的论文摘要以及贝塞斯达会议关于心血管疾病当前主题的报告和建议。
期刊主页投稿网址涉及主题 | 医学内科学心脏病学生物外科心理学放射科精神科心肌梗塞病理内分泌学化学物理 |
出版信息 | 出版商: Elsevier Inc.,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1983,原创研究文献占比: 80.49%,自引率:4.10%, Gold OA占比: 71.49% |
平均审稿周期 | 网友分享经验:较快,2-4周 |
平均录用比例 | 网友分享经验:很难 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Pediatric Sedation Gets a Wake-Up Call
2024-9-1
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
2024-9-1
Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
2024-9-1
Significance of B-Type Natriuretic Peptide Level in Patients With Small Left Ventricle
2024-9-1
Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention
2024-9-1
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction
2024-9-1
Temporal Trends in Takotsubo Syndrome
2024-9-1
Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF?
2024-9-1
The Alarming Surge of Atrial Fibrillation in the United States
2024-9-1
Metabolic Surgery Saves Lives
2024-9-1
Effect of Evogliptin on the Progression of Aortic Valvular Calcification
2024-9-1
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy
2024-9-1
Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood
2024-9-1
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
2024-9-1
Triglycerides and Cardiovascular Risk
2024-9-1
Exploring the Need for Precise MI Adjudication in Clinical Trials
2024-9-1
Rethinking Cholesterol Screening and Management in Young Adults
2024-9-1
Potential for Misapplication of a Uniform vs Sex-Specific High-Sensitivity Cardiac Troponin Threshold
2024-9-1
Competing Risks in Clinical Trials
2024-9-1
Reply
2024-9-1
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation
2024-9-1
Trusting the True Experts Through Patient-Reported Health Status in Hypertrophic Cardiomyopathy
2024-9-1
Unveiling the Unseen: Myosin Inhibitors Cause Reverse Remodeling of Left Ventricular Macro and Microstructure by CMR
2024-9-1
Contents
2024-9-1
Audio Summary
2024-9-1
Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With Heart Failure?
2024-9-1
Finding Truth in Observational and Interventional Studies in Diabetes and Cardiovascular Disease
2024-9-1
Medical Therapy for Aortic Stenosis
2024-9-1
Genotype-Guided Antiplatelet Therapy
2024-9-1
Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension
2024-9-1
Contents
2024-9-1
Finding the right needle in the haystack: the real challenge of AF screening
2024-9-1
Contents
2024-9-1
Audio Summary
2024-9-1
Association of Postnatal Opioid Exposure and 2-Year Neurodevelopmental Outcomes in Infants Undergoing Cardiac Surgery
2024-9-1
Reply
2024-9-1
Reply
2024-9-1
Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden
2024-9-1
Balancing the Climate Equation
2024-9-1
Bridging Atrial and Ventricular Failure Through Biomarkers
2024-9-1
Echocardiographic changes with Aficamten: A pixel is worth 1024 bits
2024-9-1
Unraveling the Mysteries Surrounding Takotsubo Syndrome
2024-9-1
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy
2024-9-1
Minimum National Prevalence of Diagnosed Atrial Fibrillation Inferred From California Acute Care Facilities
2024-9-1
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes
2024-9-1
Bleeding and Thrombosis in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention
2024-9-1
Improving Health Status With SGLT2 Inhibitors Following Worsening Heart Failure
2024-9-1
Fucosylation
2024-9-1
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure
2024-9-1
The Association of Bradycardic Event Risk With Antiarrhythmic Drugs for Atrial Fibrillation
2024-9-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远